Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LipAge: Autologous MSCs + HA for Lipodystrophy
NCT02034786Phase 1Unknown
- Sponsor
- Cryopraxis
- Start
- Mar 2015
- Primary completion
- May 2016
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of autologous adipose-derived mesenchymal stromal cells in lipodystrophy (2 arms), sponsored by Cryopraxis. Primary endpoint: Adverse Events Analysis at 12 months. Status: unknown.
02
Drugs
autologous adipose-derived mesenchymal stromal cells
03
Conditions
lipodystrophy
Beyond the preview
Go deeper on NCT02034786.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02034786.